Total-body irradiation in advanced non-Hodgkin's lymphoma

The British Journal of Radiology
H J DobbsM J Peckham

Abstract

Thirty-seven patients with advanced non-Hodgkin's lymphoma who were treated by total-body irradiation (TBI) at the Royal Marsden Hospital are reviewed. Twenty-four patients had received no previous therapy; 13 patients were in relapse. The overall response rate was 73% for nodular lymphomas and 80% for those with diffuse disease. THe duration of complete response ranged from two to 41 months (median 12 months). Subsequent chemotherapy was given successfully except in patients with prolonged thrombocytopenia which appeared to be related to an initially involved bone marrow. Hemibody irradiation (HBI) was the least myelosuppressive form of TBI and is now being used in complete remission following chemotherapy.

References

Feb 1, 1979·International Journal of Radiation Oncology, Biology, Physics·T L TharW D Noyes
Jan 1, 1979·Clinical Radiology·J M HaefligerG G Steel
Mar 1, 1976·International Journal of Radiation Oncology, Biology, Physics·J T ChaffeyS Hellman
Jul 1, 1980·Clinical Radiology·G J ReesN C Pizey

❮ Previous
Next ❯

Citations

Nov 11, 2005·Medical Physics·Susanta K HuiJames S Welsh
Jun 28, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A Safwat
Feb 2, 2006·International Journal of Radiation Biology·Takashi TanakaShuji Kojima
Apr 1, 1986·European Journal of Cancer & Clinical Oncology·B MascretG Novakovitch
Mar 7, 2009·Hematological Oncology·R L M Haas
Apr 17, 2008·Journal of Radiation Research·Hiroko NakatsukasaShuji Kojima
Mar 6, 2021·Critical Reviews in Oncology/hematology·Marek K JaniakJames S Welsh
Nov 15, 2011·The American Journal of Pathology·Atsushi OtaniNagahisa Yoshimura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.